The Laboratory of Molecular Immunology at the Rockefeller University conducts an active Phase 1 research program with the goal of understanding the human immune system’s response to viral infection. We are actively studying HIV and Hepatitis B and planning to bring additional anti-viral human monoclonal antibodies into the clinic over the next 5 years as our program continues to expand with the support of public and private funding. Our partners and collaborators in the US, EU, Africa and South America are a vital component of our leading edge global clinical research program.
The Rockefeller University does not discriminate in employment on the basis of race, color, religion, sex (including pregnancy, gender identity), national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, membership in an employee organization, retaliation, parental status, military service or other non-merit factor. All qualified applicants will receive consideration for employment without regard to the characteristics listed above.
The salary of the finalist selected for this role will be set based on various factors, including but not limited to organizational budgets, qualifications, experience, education, licenses, specialty, and training. The hiring range provided represents The Rockefeller University's good faith and reasonable estimate of the range of possible compensation at the time of posting.